Our Company
Discovering and developing innovative therapies for patients with challenging brain and nervous system disorders
Therapeutic innovation
to improve patients’ lives
Discovering & developing
innovative therapies for
challenging disorders of the
brain and nervous system
Our Platform
Producing therapies with novel chemistry that modulate NMDA receptors, which are vital to normal brain physiology, and restore normal balance in the brain & CNS
Our Development Programs
Advancing late-stage assets across chronic pain, post-traumatic stress disorder, and cognitive impairment
Latest News
September 20, 2021
Aptinyx to Participate in 2021 Cantor Virtual Global Healthcare Conference
September 16, 2021
Aptinyx Secures $50 Million Growth Capital Credit Facility from K2